Home/Filings/4/0001214659-18-000192
4//SEC Filing

Rasdal Andrew P 4

Accession 0001214659-18-000192

CIK 0001427570other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:17 PM ET

Size

5.5 KB

Accession

0001214659-18-000192

Insider Transaction Report

Form 4
Period: 2018-01-02
Rasdal Andrew P
DirectorPresident & CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-01-02+300,000300,000 total
    Exercise: $7.15Exp: 2028-01-02Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date.

Issuer

OBALON THERAPEUTICS INC

CIK 0001427570

Entity typeother

Related Parties

1
  • filerCIK 0001323238

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:17 PM ET
Size
5.5 KB